Immunogenicity and safety of the RTS,S/AS01 malaria vaccine co-administered with measles, rubella and yellow fever vaccines in Ghanaian children: A phase IIIb, multi-center, non-inferiority, randomized, open, controlled trial

BACKGROUND: To optimize vaccine implementation visits for young children, it could be efficient to administer the first RTS,S/AS01 malaria vaccine dose during the Expanded Programme on Immunization (EPI) visit at 6 months of age together with Vitamin A supplementation and the third RTS,S/AS01 dose o...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:Vaccine
المؤلفون الرئيسيون: Asante, Kwaku Poku, Ansong, Daniel, Kaali, Seyram, Adjei, Samuel, Lievens, Marc, Badu, Lydia Nana, Darko, Prince Agyapong, Buabeng, Patrick Boakye Yiadom, Boahen, Owusu, Rettig, Theresa Maria, Agutu, Clara, Harrison, Samuel Benard Ekow, Ntiamoah, Yaw, Anim, Japhet Adomako, Adeniji, Elisha, Dornudo, Albert Agordo, Gvozdenovic, Emilia, Dosoo, David, Sambian, David, Owusu-Boateng, Harry, Wilson, Elvis Ato, Prempeh, Frank, Vandoolaeghe, Pascale, Schuerman, Lode, Owusu-Agyei, Seth, Agbenyega, Tsiri, Ofori-Anyinam, Opokua
التنسيق: Artigo
اللغة:Inglês
منشور في: 2020
الموضوعات:
Article
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC7611265/
https://ncbi.nlm.nih.gov/pubmed/32192811
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2020.03.014
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة